Adenocarcinoma left lung

2021-01-15 12:40:35
Patient data suggests that non-small cell lung cancer with mutations in the tyrosine kinase domain ( Exon 18- 21) of the EGFR gene may respond to anti-EGFR therapies directed against the tyrosine kinase domain.
66 Views
Yes. That's true. Targeted therapy in the form of anti EGFR drugs have proven effective in lung cancer patients with EGFR gene mutations.

Answered2021-01-15 12:52:55

Was this answer useful

Not finding what you need? Ask Practo AI

FREE

Chat with Practo AI on Whatsapp

That is right...
Next Steps
you should consider treatment.. lot of options are available

Answered2021-01-15 12:47:34

Was this answer useful

Not finding what you need? Ask Practo AI

FREE

Chat with Practo AI on Whatsapp

Disclaimer : The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding your medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.